In a pharmaceuticals industry dominated by giant corporations, Cambrex Corp. views its relatively modest size as an advantage.
“It’s a nice-sized company,” says Simon Edwards, vice president of global sales and business development. “It’s a mid-sized company with a really good balance. It’s almost a unique balance because we have custom manufacturing, generic API and formulated drug product capabilities. We are not a big behemoth and are small enough to be customer-focused.”
Cambrex serves customers ranging from multinational pharmaceutical companies to small and emerging biotechnology companies. “We work with customers of all sizes and don’t just do big blockbusters,” Edwards says. “We are really flexible with customers and market-focused for both generic and custom manufacturing.”